WHO Members To Work To Disentangle Problem Of Fake Medicines, IP Issues 26/02/2011 by Catherine Saez, Intellectual Property Watch Leave a Comment A designated working group will meet for the first time this week to discuss the World Health Organization’s role in the safety, quality and efficacy of medical products, but some countries are concerned about what they consider to be the unwelcome intrusion of intellectual property rights issues into the debate.
Building A Consensus To Address The Health Threat Posed By Fake Medicines 25/02/2011 by Intellectual Property Watch 1 Comment On the eve of a meeting of the WHO working group on substandard/spurious/falsely-labelled/falsified/counterfeit medical products, research-based pharmaceutical industry group IFPMA sets out thoughts on building global consensus to address fake medicines.
Experts: L’Application D’un Nouveau Protocole Sur La Biodiversité Repose Sur Les Réglementations Nationales 21/02/2011 by Catherine Saez, Intellectual Property Watch Leave a Comment PARIS – Récemment adopté, l’accord international pour faciliter l’accès aux ressources génétiques et le partage équitable des ressources en découlant a été ouvert à la ratification la semaine dernière. Le texte a d’ores et déjà reçu des commentaires mitigés des parties prenantes.
Stronger IP Rights In EU-Korea FTA: Precedent For Future FTAs? 20/02/2011 by Monika Ermert for Intellectual Property Watch 9 Comments A European Parliament majority this week approved a free trade agreement with Korea with strong provisions on intellectual property rights protection, according to Robert Stury, rapporteur of the lead EP Committee on the dossier.
WHO, WTO, WIPO Combine Forces To Improve Patent Information For Public Health 18/02/2011 by Catherine Saez, Intellectual Property Watch 1 Comment Patents and public health are sometimes seen as a mismatch, but three prominent international organisations today stepped up their collaboration on ways to facilitate access to medicines by making a better use of the patent system. Effective, reliable and transparent information on patents is necessary to help decision-makers take the best public health approaches for global health coverage, panellists said.
Brazil And The Defence Of Public Health: Do As I Say, Not As I Do 17/02/2011 by Intellectual Property Watch 3 Comments A recent decision issued by Advocacia-Geral da União (Advocacy-General of the Union) restricts the role performed by Anvisa – the National Agency for Health Surveillance – in examining pharmaceutical patent applications. This may represent a huge setback for commitments made by Brazilian government related to the protection of public health, writes Felipe Carvalho.
Pharma Backs Calls For Extension Of TRIPS Deadline For Least-Developed Countries 10/02/2011 by William New, Intellectual Property Watch 1 Comment Developed country pharmaceutical companies today announced their support for an extension of the deadline for poor countries to comply with a global trade agreement on intellectual property rights that would significantly raise their obligations to protect IP. The extension idea has been proposed by the United Kingdom government in a new trade strategy document.
New Biodiversity Benefit-Sharing Protocol Relies On National Rules, Experts Say 07/02/2011 by Catherine Saez, Intellectual Property Watch 1 Comment PARIS – The recently agreed international instrument to facilitate access to genetic resources and the equitable sharing of benefits accrued from those resources opened for signature last week, and the text is already getting mixed reviews from stakeholders.
Panel: Seek Innovative Solutions Vs. Counterfeiting; Oxfam Warns Against False Solution 04/02/2011 by Catherine Saez, Intellectual Property Watch Leave a Comment PARIS – The rise of counterfeiting and global economic difficulties combined to sap resources devoted to intellectual property enforcement, said panellists at an event highlighting the fight against counterfeiting and piracy yesterday, and discussed innovative solutions. Meanwhile a civil society group said enforcement of IP rights is a false solution to substandard medicines.
Counterfeit Congress Gives Nod To Developing Country Concerns 04/02/2011 by Catherine Saez, Intellectual Property Watch 4 Comments PARIS – Sustainable development made what some described as a welcome intrusion at the global congress on counterfeiting and piracy during a dedicated session on Wednesday, with discussions on how to conduct enforcement efforts while taking into account developing country specificities.